Advisory Services Network, LLC Ascendis Pharma A/S Transaction History

Advisory Services Network, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$86.1 - $127.36 $12,484 - $18,467	145 New	145 $18,000
Q1 2023 May 17, 2023	SELL	$104.9 - $126.78 $37,344 - $45,133	-356 Reduced 71.49%	142 $15,000
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $49,511 - $65,721	498 New	498 $60,000
Q3 2021 Nov 05, 2021	SELL	$112.67 - $176.92 $9,238 - $14,507	-82 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$121.62 - $145.29 $9,972 - $11,913	82 New	82 $11,000
Q1 2021 May 24, 2021	SELL	$124.92 - $173.33 $92,066 - $127,744	-737 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$151.2 - $182.76 $5,745 - $6,944	-38 Reduced 4.9%	737 $123,000
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $104,074 - $119,598	775 New	775 $120,000
Q2 2020 Aug 10, 2020	SELL	$110.87 - $156.01 $443 - $624	-4 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$97.01 - $145.11 $388 - $580	4 New	4 $0
Q4 2019 Feb 04, 2020	SELL	$91.45 - $139.12 $7,133 - $10,851	-78 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$107.11 - $132.09 $8,354 - $10,303	78 New	78 $0
Q4 2018 Feb 15, 2019	SELL	$55.16 - $69.67 $496 - $627	-9 Closed	0 $0
Q2 2018 Jul 27, 2018	BUY	$58.55 - $73.92 $526 - $665	9 New	9 $1,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.